The McGill University Health Centre(MUHC) participated in the launching today of a Hemodialysis Clinic in Chibougamau as a full partner in this innovative health care initiative."Over the past year leading up to today's launching, the Hemodialysis Clinic at the Montreal General Hospital(MGH) has provided expertise and support on three levels," says Dr. Murray Vasilevsky, Chief of Nephrology and Director of the MGH Dialysis Clinic.
The McGill University Health Centre (MUHC) is pleased to announce that effective April 1, 2001, a network of physicians specialized in HIV/AIDS will make it possible for Consultation SIDA, coordinated by the Montreal Chest Institute of the Royal Victoria Hospital, to offer its telephone consultation service on a 24/7 basis.
The McGill University Health Centre (MUHC) inaugurates today its new Sleep Disorders Centre, the result of the merger of the two adult centres from the Royal Victoria(RVH) and the Montreal General(MGH) sites. Construction was completed in December 2000 on the 10th Floor of the "F" Pavilion at the Royal Victoria Hospital site.
Quebec Minister of Health and Social Services, Rémy Trudel, today announced the purchase of the Canadian Pacific's Glen Yards as the future site of the McGill University Health Centre (MUHC).
The following message was sent today to all personnel of the MUHC by Executive Director, Dr Hugh Scott.
Montreal, February 19, 2002 - The McGill University Health Centre (MUHC) proudly opened its newly renovated 24-bed Intensive Care Unit during a ribbon cutting ceremony today at the Montreal General Hospital (MGH) site.
The McGill University Health Centre (MUHC) becomes one of the first Canadian health institutions to formally adopt a disclosure policy. The hospital will let patients know when medical errors are made or when unplanned outcomes of procedures occur.
The Board of Directors of the McGill University Health Centre (MUHC) has received the final report of an operational review of its financial, administrative and clinical activities.
Action ABC, a literacy program for individuals with life challenges, will launch a unique book entitled The Writer's Pen, on Tuesday, November 27, in collaboration with The Montreal General Hospital of the McGill University Health Centre, The Jewish General Hospital, The Douglas Hospital and The Centre for Addiction and Mental Health.
The first clinical trials of INGAP Peptide for the treatment of patients with diabetes mellitus have begun in the United States. INGAP Peptide derives from discoveries made by Dr. Lawrence Rosenberg, Professor of Surgery and Medicine and Director of the Division of Surgical Research at the McGill University Health Centre (MUHC) and Dr. Aaron I. Vinik, Professor of Medicine, Anatomy and Neurobiology and Director of the Strelitz Diabetes Institutes at Eastern Virginia Medical School.